Literature DB >> 11909831

Cardiotoxicity of fluoroquinolones.

Ethan Rubinstein1, John Camm.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11909831     DOI： 10.1093/jac/49.4.593

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  28 in total

1.  Role of mixed ion channel effects in the cardiovascular safety assessment of the novel anti-MRSA fluoroquinolone JNJ-Q2.

Authors:  G Eichenbaum; M K Pugsley; D J Gallacher; R Towart; G McIntyre; U Shukla; J M Davenport; H R Lu; J Rohrbacher; V Hillsamer
Journal:  Br J Pharmacol       Date:  2012-07       Impact factor: 8.739

Review 2.  Acquired prolongation of QT interval as a risk factor for torsade de pointes ventricular tachycardia: a narrative review for the anesthesiologist and intensivist.

Authors:  Arsen Uvelin; Jasmina Pejaković; Vesna Mijatović
Journal:  J Anesth       Date:  2017-02-22       Impact factor: 2.078

Review 3.  Microbiome at the Frontier of Personalized Medicine.

Authors:  Purna C Kashyap; Nicholas Chia; Heidi Nelson; Eran Segal; Eran Elinav
Journal:  Mayo Clin Proc       Date:  2017-12       Impact factor: 7.616

Review 4.  Safety considerations of fluoroquinolones in the elderly: an update.

Authors:  Ralf Stahlmann; Hartmut Lode
Journal:  Drugs Aging       Date:  2010-03-01       Impact factor: 3.923

Review 5.  Safety profile of the fluoroquinolones: focus on levofloxacin.

Authors:  Hans H Liu
Journal:  Drug Saf       Date:  2010-05-01       Impact factor: 5.606

Review 6.  Drugs in development for tuberculosis.

Authors:  Ann M Ginsberg
Journal:  Drugs       Date:  2010-12-03       Impact factor: 9.546

7.  Levofloxacin can be used effectively as a positive control in thorough QT/QTc studies in healthy volunteers.

Authors:  Jorg Taubel; Asif Naseem; Tomohiko Harada; Duolao Wang; Radivoj Arezina; Ulrike Lorch; A John Camm
Journal:  Br J Clin Pharmacol       Date:  2010-04       Impact factor: 4.335

8.  [Severe bacterial infection: increased mortality in elderly women with low body weight taking drugs prolonging the QTc interval].

Authors:  S Suefke; H Djonlagić; T Kibbel
Journal:  Med Klin Intensivmed Notfmed       Date:  2012-04-29       Impact factor: 0.840

Review 9.  Fluoroquinolones in the elderly: safety considerations.

Authors:  Ralf Stahlmann; Hartmut Lode
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

Review 10.  Pharmacogenetic aspects of drug-induced torsade de pointes: potential tool for improving clinical drug development and prescribing.

Authors:  Rashmi R Shah
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.